Login / Signup

Impact of Programmed Death Ligand 1 Expression in Advanced Non-Small-Cell Lung Cancer Patients, Treated by Chemotherapy (GFPC 06-2015 Study).

Jean-Bernard AuliacFlorian GuisierAcya BizieuxPascal AssoulineMarie BernardiniRégine LamyGrégoire JusteauGeraldine FrançoisDiane DamotteChristos Chouaid
Published in: OncoTargets and therapy (2020)
According to the results of this prospective, multicenter study, neither TC nor IC PD-L1 expression appears to be prognostic for chemotherapy-managed advanced NSCLC patients.
Keyphrases